Parallel Advisors’s CollPlant Biotechnologies OPHI Stock Holding History
Bought
Maintained
Sold
Other funds holding OPHI
Parallel Advisors's OPHI Position: Q3 2026 in Review
Parallel Advisors sold out of CollPlant Biotechnologies (OPHI) in Q3 2026, closing a stake of 7 shares — an estimated $25 sold.
Parallel Advisors first reported a position in OPHI in Q4 2020 and held it in 23 quarters. The position peaked at $360K in Q3 2021. 7 funds tracked by Wall St. Rank hold OPHI as of Q3 2026.
- Parallel Advisors reported no remaining CollPlant Biotechnologies position as of Q3 2026 after selling out during the quarter.
- Parallel Advisors sold 7 CollPlant Biotechnologies shares in Q3 2026, an estimated $25.
- Parallel Advisors first reported a position in CollPlant Biotechnologies in Q4 2020 and held it in 23 quarters.
- Parallel Advisors's CollPlant Biotechnologies position peaked at $360K in Q3 2021.
- 7 funds tracked by Wall St. Rank held CollPlant Biotechnologies as of Q3 2026.
Based on Parallel Advisors's 13F filing for Q3 2026, filed 3 Nov 2026.